Get the Stockscreener App
0.00
100.00%
-5.27
After Hours:
4.65
4.65
+
Regencell Bioscience Holdings Ltd stock is currently priced at $0.00, with a 24-hour trading volume of 0.
It has seen a -100.00% decreased in the last 24 hours and a -100.00% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $5.06 pivot point. If it approaches the $4.22 support level, significant changes may occur.
Previous Close:
$5.27
Open:
$0
24h Volume:
0
Market Cap:
$68.58M
Revenue:
-
Net Income/Loss:
$-5.87M
P/E Ratio:
0.00
EPS:
-0.54
Net Cash Flow:
$-767.30K
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1D Range:
$0.00
$0.00
52W Range:
$0.00
$30.49
Regencell Bioscience Holdings Ltd Stock (RGC) Company Profile
Name
Regencell Bioscience Holdings Ltd
Sector
Phone
852 2155 0823
Address
First Commercial Building, 11th Floor 33-35 Leighton Road, Causeway Bay
Regencell Bioscience Holdings Ltd Stock (RGC) Financials Data
Regencell Bioscience Holdings Ltd (RGC) Net Income 2024
RGC net income (TTM) was -$5.87 million for the quarter ending June 30, 2023, a -335.96% decrease year-over-year.
Regencell Bioscience Holdings Ltd (RGC) Cash Flow 2024
RGC recorded a free cash flow (TTM) of -$767.30 thousand for the quarter ending June 30, 2021.
Regencell Bioscience Holdings Ltd (RGC) Earnings per Share 2024
RGC earnings per share (TTM) was -$0.45 for the quarter ending June 30, 2023, a -322.54% decline year-over-year.
About Regencell Bioscience Holdings Ltd
Regencell Bioscience Holdings Limited operates a traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
0.08%
1.28%
Cap:
|
Volume (24h):